Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.3.268

Drug-Induced Nephrotoxicity and Its Biomarkers  

Kim, Sun-Young (College of Pharmacy, Duksung Women's University)
Moon, A-Ree (College of Pharmacy, Duksung Women's University)
Publication Information
Biomolecules & Therapeutics / v.20, no.3, 2012 , pp. 268-272 More about this Journal
Abstract
Nephrotoxicity occurs when kidney-specific detoxification and excretion do not work properly due to the damage or destruction of kidney function by exogenous or endogenous toxicants. Exposure to drugs often results in toxicity in kidney which represents the major control system maintaining homeostasis of body and thus is especially susceptible to xenobiotics. Understanding the toxic mechanisms for nephrotoxicity provides useful information on the development of drugs with therapeutic benefits with reduced side effects. Mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation, crystal nephropathy, rhabdomyolysis, and thrombotic microangiopathy. Biomarkers have been identified for the assessment of nephrotoxicity. The discovery and development of novel biomarkers that can diagnose kidney damage earlier and more accurately are needed for effective prevention of drug-induced nephrotoxicity. Although some of them fail to confer specificity and sensitivity, several promising candidates of biomarkers were recently proved for assessment of nephrotoxicity. In this review, we summarize mechanisms of drug-induced nephrotoxicity and present the list of drugs that cause nephrotoxicity and biomarkers that can be used for early assessment of nephrotoxicity.
Keywords
Biomarker; Nephrotoxicity; Assessment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kharasch, E. D., Schroeder, J. L., Bammler, T., Beyer, R. and Srinouanprachanh, S. (2006) Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difl uoro- 1-(trifluoromethyl)vinyl ether ("compound A") in rats. Toxicol. Sci. 90, 419-431.
2 Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E. and Gibson, C. M; TIMI Study Group. (2005) Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J. Am. Coll. Cardiol. 45, 1781-1786.   DOI
3 Kohli, H. S., Bhaskaran, M. C., Muthukumar, T., Thennarasu, K., Sud, K., Jha, V., Gupta, K. L. and Sakhuja. V. (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol. Dial. Transplant. 15, 212-217.   DOI
4 Manor, S. M., Guillory, G. S. and Jain, S. P. (2004) Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting. Pharmacotherapy 24, 664-667.   DOI
5 Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S. and D'Agati, V. D. (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 64, 281-289.   DOI
6 Markowitz, G. S. and Perazella MA. (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. Clin. Chim. Acta 351, 31-47.   DOI
7 Mogensen, C. E. (1971) Urinary albumin excretion in early and longterm juvenile diabetes. Scand. J. Clin. Lab. Invest. 28, 101-109.   DOI
8 Nagai, J. and Takano, M. (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin. Drug Metab. Toxicol. 6, 1125-1138.   DOI
9 Ferguson, M. A., Vaidya, V. S. and Bonventre, J. V. (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245, 182-193.   DOI
10 Finn, W. and Porter, G. (2003) Urinary biomarkers and nephrotoxicity. Clinical Nephrotoxins (2nd ed), pp. 621-655. Kluwer Academic Publishers, Massachusetts.
11 Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C. G., Blot, W. J., McLaughlin, J. K., Zack, M. M. and Nyren, O. (2001) Acetaminophen, aspirin, and chronic renal failure. N. Engl. J. Med. 345, 1801-1808.   DOI
12 Galley, H. F. (2000) Can acute renal failure be prevented? J. R. Coll. Surg. Edinb. 45, 44-50.
13 Guder, W.G. and Hoffmann, W. (1992) Markers for the diagnosis and monitoring of renal tubular lesions. Clin. Nephrol. 38(Suppl 1), s3-7.
14 Herget-Rosenthal, S., Poppen, D., Husing, J., Marggraf, G., Pietruck, F., Jakob, H. G., Philipp, T. and Kribben, A. (2004) Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin. Chem. 50, 552-558.   DOI
15 Horii, Y., Iwano, M., Hirata, E., Shiiki, M., Fujii, Y., Dohi, K. and Ishikawa, H. (1993) Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int. 39(Suppl), S71-75.
16 Huerta-Alardín, A. L., Varon, J. and Marik, P. E. (2005) Bench-tobedside review: Rhabdomyolysis -- an overview for clinicians. Crit. Care 9, 158-169.   DOI   ScienceOn
17 Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M. and Bonventre, J. V. (2002) Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 277, 39739-39748.   DOI
18 Ichimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L. and Sanicola, M. (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135-4142.   DOI
19 Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M. and Vanherweghem, J. L. (2004) Herbs and the kidney. Am. J. Kidney Dis. 44, 1-11.
20 Alchi, B., Nishi, S., Kondo, D., Kaneko, Y., Matsuki, A., Imai, N., Ueno M., Iguchi, S., Sakatsume, M., Narita, I., Yamamoto, T. and Gejyo, F. (2005) Osteopontin expression in acute renal allograft rejection. Kidney Int. 67, 886-896.   DOI
21 Baron, S., Tyring, S. K., Fleischmann, W. R. Jr., Coppenhaver, D. H., Niesel, D. W., Klimpel, G. R., Stanton, G. J. and Hughes, T. K. (1991) The interferons. Mechanisms of action and clinical applications. JAMA 266, 1375-1383.   DOI
22 Bernard, A. M., Vyskocil, A. A., Mahieu, P. and Lauwerys, R. R. (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin. Chem. 33, 775-779.
23 Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. and Dieterle, F. (2010) Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28, 436-440.   DOI
24 Borregaard, N., Sehested, M., Nielsen, B. S., Sengeløv, H. and Kjeldsen, L. (1995) Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85, 812-817.
25 Coco, T. J. and Klasner, A. E. (2004) Drug-induced rhabdomyolysis. Curr. Opin. Pediatr. 16, 206-210.   DOI
26 Wu, Y., Yang, L., Su, T., Wang, C., Liu, G. and Li, X. M. (2010) Pathological signifi cance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. Clin. J. Am. Soc. Nephrol. 5, 1954-1959.   DOI
27 Conti, M., Moutereau, S., Zater, M., Lallali, K., Durrbach, A., Manivet, P., Eschwège, P. and Loric, S. (2006) Urinary cystatin C as a specific marker of tubular dysfunction. Clin. Chem. Lab. Med. 44, 288-291.
28 Donovan, K. L., Coles, G. A. and Williams, J. D. (1994) An ELISA for the detection of type IV collagen in human urine--application to patients with glomerulonephritis. Kidney Int. 46, 1431-1437.   DOI
29 Emeigh Hart, S. G. (2005) Assessment of renal injury in vivo. J. Pharmacol. Toxicol. Methods 52, 30-45.   DOI
30 Wada, T., Yokoyama, H., Tomosugi, N., Hisada, Y., Ohta, S., Naito, T., Kobayashi, K., Mukaida, N. and Matsushima, K. (1994) Detection of urinary interleukin-8 in glomerular diseases. Kidney Int. 46, 455-460.   DOI
31 Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., Zhang, D., Yin, J., Wang, Z., Sun, W., Zhang, Z. and Gao, Y. (2011) A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol. Cell Proteomics 10, M111.010975.
32 Xu, S. Y., Pauksen, K. and Venge, P. (1995) Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand. J. Clin. Lab. Invest. 55, 125-131.   DOI
33 Zager, R. A. (1997) Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin. Nephrol. 17, 3-14.
34 Schnellmann, R.G. and Kelly, K.J. (1999). Pathophysiology of nephrotoxic acute renal failure, in atlas of diseases of the kidney vol 1. (R. W. Schrier, Ed.), pp 15.1-15.14. Blackwell Science (Wash DC) Ltd., Oxford.
35 Schoolwerth, A. C., Sica, D. A., Ballermann, B. J. and Wilcox, C. S; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104, 1985-1991.   DOI
36 Schurek, H. J., Neumann, K. H., Flohr, H., Zeh, M.and Stolte, H. (2000) Diagnostic and prognostic signifi cance of proteinuria selectivity index in glomerular diseases. Clin. Chim. Acta 297, 73-83.   DOI
37 Shiraga, H., Min, W., Van Dusen, W.J., Clayman, M.D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., Neilson, E. G. and Hoyer, J. R. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acidrich protein superfamily. Proc. Natl. Acad. Sci. USA 89, 426-430.   DOI   ScienceOn
38 Vaidya, V. S., Ferguson, M. A. and Bonventre, J. V. (2008) Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493.   DOI
39 Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A. and Bonventre, J. V. (2006) Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal. Physiol. 290, F517-529.   DOI
40 Perazella, M. A. (1999) Crystal-induced acute renal failure. Am. J. Med. 106, 459-465.   DOI
41 Prinsen, B. H., de Sain-van der Velden, M. G., Kaysen, G. A., Straver, H. W., van Rijn, H. J., Stellaard, F., Berger, R. and Rabelink, T. J. (2001) Transferrin synthesis is increased in nephrotic patients insuffi ciently to replace urinary losses. J. Am. Soc. Nephrol. 12, 1017-1025.
42 Perazella, M. A. (2005) Drug-induced nephropathy: an update. Expert Opin. Drug Saf. 4, 689-706.   DOI
43 Perneger, T. V., Whelton, P. K. and Klag, M. J. (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinfl ammatory drugs. N. Engl. J. Med. 331, 1675-1679.   DOI
44 Pisoni, R., Ruggenenti, P. and Remuzzi, G. (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf. 24, 491-501.   DOI
45 Rached E., Hoffmann, D., Blumbach, K., Weber, K., Dekant, W. and Mally, A. (2008) Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol. Sci. 103, 371-381.   DOI
46 Rodriguez-Iturbe, B. and Garcia Garcia, G. (2010) The role of tubulointerstitial infl ammation in the progression of chronic renal failure. Nephron. Clin. Pract. 116, c81-c88.   DOI
47 Rossert, J. (2001) Drug-induced acute interstitial nephritis. Kidney Int. 60, 804-817.   DOI   ScienceOn
48 Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D. and Nickerson, P. (2005) Proteomic-based identifi cation of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 5, 729-738.   DOI
49 Schetz, M., Dasta, J., Goldstein, S. and Golper, T. (2005) Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11, 555-565.   DOI
50 Naughton, C. A. (2008) Drug-induced nephrotoxicity. Am. Fam. Physician. 78, 743-750.
51 Nerlich, A. G., Schleicher, E. D., Wiest, I., Specks, U. and Timpl, R. (1994) Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int. 45, 1648-1656.   DOI
52 Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M. and Kjeldsen, L. (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and infl ammatory bowel diseases. Gut 38, 414-420.   DOI
53 Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K. and Hogan, B. L. (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106, 441-450.   DOI   ScienceOn
54 Ohlsson, S., Wieslander, J. and Segelmark, M. (2003) Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin. Exp. Immunol. 131, 528-535.   DOI
55 Oldberg, A., Franzen, A. and Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. USA 83, 8819-8823.   DOI   ScienceOn
56 Olyaei, A. J., de Mattos, A. M. and Bennett, W. M. (1999) Immunosuppressant- induced nephropathy: pathophysiology, incidence and management. Drug Saf. 21, 471-488.   DOI
57 Palmer, B. F. (2002) Renal dysfunction complicating the treatment of hypertension. N. Engl. J. Med. 347, 1256-1261.   DOI
58 Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kojak, C. A., Mock, B. A., Morse, H. C., Jerrells, T. R. and Cantor, H. (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: Definition of a novel T cell dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170, 145-161.   DOI   ScienceOn